Schistosoma mansoni: chemotherapy of infections of different ages
- PMID: 3086114
- DOI: 10.1016/0014-4894(86)90184-0
Schistosoma mansoni: chemotherapy of infections of different ages
Abstract
Mice were treated with potassium antimony tartrate, hycanthone, oxamniquine, niridazole, or praziquantel at different times after infection with Schistosoma mansoni. The rate of cure was assessed by perfusion of surviving worms approximately 4 weeks after treatment, and the percentage reduction in worm burden was estimated relative to the number of adult worms perfused from control mice, comparably infected but untreated. All six drugs were relatively inactive against S. mansoni between 3 and 4 weeks after infection when compared with treatment at 5 to 6 weeks. However, the drugs differed in the patterns of cure they achieved in the 2-week period after administration of cercariae and in the period around the onset of patency. Worms that had been subjected to amoscanate or hycanthone in the third week after infection showed evidence of this as adults in having a reduced fecundity. Factors such as worm or host physiology, or host immune status may have had roles in the outcome of chemotherapy at different stages of maturation of S. mansoni.
Similar articles
-
Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice.Exp Parasitol. 1985 Dec;60(3):348-54. doi: 10.1016/0014-4894(85)90041-4. Exp Parasitol. 1985. PMID: 3935473
-
Current results in the clinical therapy of schistosomiasis mansoni.Rev Inst Med Trop Sao Paulo. 1980 Jan-Feb;22(1 Suppl 4):8-17, 123-33. Rev Inst Med Trop Sao Paulo. 1980. PMID: 7006041 Review. English, Portuguese. No abstract available.
-
Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. V. Reduction in the degree of resistance to reinfection after chemotherapeutic elimination of recently patent primary infections.J Helminthol. 1980 Mar;54(1):7-16. doi: 10.1017/s0022149x0000626x. J Helminthol. 1980. PMID: 7373025
-
[Treatment of schistosomiasis mansoni].Rev Paul Med. 1982 Mar-Apr;99(2):26-8. Rev Paul Med. 1982. PMID: 7156674 Portuguese. No abstract available.
-
The chemotherapy of schistosomiasis.Annu Rev Pharmacol Toxicol. 1985;25:485-508. doi: 10.1146/annurev.pa.25.040185.002413. Annu Rev Pharmacol Toxicol. 1985. PMID: 3890709 Review. No abstract available.
Cited by
-
Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models.PLoS Negl Trop Dis. 2020 Sep 25;14(9):e0008649. doi: 10.1371/journal.pntd.0008649. eCollection 2020 Sep. PLoS Negl Trop Dis. 2020. PMID: 32976496 Free PMC article. Review.
-
Global Assessment of Schistosomiasis Control Over the Past Century Shows Targeting the Snail Intermediate Host Works Best.PLoS Negl Trop Dis. 2016 Jul 21;10(7):e0004794. doi: 10.1371/journal.pntd.0004794. eCollection 2016 Jul. PLoS Negl Trop Dis. 2016. PMID: 27441556 Free PMC article.
-
Epidemiology of schistosomiasis in two high-risk communities of south Cote d'Ivoire with particular emphasis on pre-school-aged children.Am J Trop Med Hyg. 2013 Jul;89(1):32-41. doi: 10.4269/ajtmh.12-0346. Epub 2013 May 20. Am J Trop Med Hyg. 2013. PMID: 23690549 Free PMC article.
-
Natural products as a source for treating neglected parasitic diseases.Int J Mol Sci. 2013 Feb 6;14(2):3395-439. doi: 10.3390/ijms14023395. Int J Mol Sci. 2013. PMID: 23389040 Free PMC article.
-
PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?Infect Disord Drug Targets. 2019;19(4):337-349. doi: 10.2174/1871526519666181231153139. Infect Disord Drug Targets. 2019. PMID: 30599112 Free PMC article. Review.